Chapter 8: Evaluation of novel blood components, production processes and blood packs: generic protocols
Chapter 5: Collection of a blood or component donation This chapter describes the steps involved in the collection of a blood or component donation from the information …
Chapter 4: Premises and quality assurance at blood donor sessions This chapter applies to the collection of donations of whole blood and components at fixed sites…
Chapter 3: Care and selection of whole blood and component donors (including donors of pre-deposit autologous blood)
CN 03-2024 - Red Book Updates Batch 3 v2.pdf (2MB)
JPAC 17-24 - Effect of irradiation on platelets_vs06.pdf (331KB)
2.2: Key initiatives 2.2.1: European Union Blood Safety and Quality Directives Commission Directive 2002/98/EC of the European Parliament and of the Council of 27 Janua…
Chapter 2: Quality in blood and tissue establishments and hospital blood banks
Role Patient Blood Management Practitioner Employer NHSBT Email
The newsletters provide information on the outputs from the UK Cell Salvage Action Group (UKCSAG). The Winter 2023 edition is now available. Topics include cell salvage and SHOT, ant…
6.2: Setting and maintaining specifications The wide variability of the source material from which blood components are prepared makes it difficult to set stringent limits. Nevertheless,…
UKCSAG Newsletter - Winter 2023.pdf (188KB)
CN 03-2024 - Red Book Updates Batch 3 v1.pdf (2MB)
7.1.2: Irradiated components For the whole of this section X-irradiation may be regarded as equivalent to gamma irradiation. Times when irradiation should be undertaken and the pe…
7.1.5: References Dumont L, Dzik W, Rebulla P, Brandwein H and members of the BEST Expert Working Party of the ISBT (1996). Practical guidelines for process validation and proces…
7.1.4: Production advice The timing and method of separation depends on the components to be prepared from a given donation. If the production, washing or splitting process tr…
7.1.3: Other component specifications Other component and process monitoring specifications are detailed later in this chapter. As far as possible, all parameters tested should be deriv…
7.1.1: Leucocyte depletion With very few stated exceptions (e.g. granulocytes), from November 1999 all allogeneic blood components produced in the UK have been subjected to a leucocyte …
6.11: Transportation of blood components 6.11.1: General considerations Donated blood and blood components should be transported by a secure system using transit containers, p…
6.10: Release of components which do not conform to specified requirements Blood and/or blood components may be issued for research, for reagent and, in exceptional cases, for therapeuti…
6.7: Component storage 6.7.1: Specifications for component storage areas Storage areas for blood components must operate within a specified temperature range and should provid…